Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SIL STRIPS
- Development stage
- Unknown
- Lead developer
- DRS Biopharma
- Modality
- Small Molecules
- Administration
- Oral, Buccal, Sublingual
01
Overview
SIL STRIPS is an orally disintegrating film (ODF) formulation of sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, developed by DRS Biopharma (DRS Industries). It is approved for the treatment of erectile dysfunction. Sildenafil works by inhibiting the PDE5 enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. By preventing cGMP breakdown, sildenafil enhances the effect of nitric oxide, leading to smooth muscle relaxation and increased blood flow to the penis during sexual stimulation. The ODF delivery system allows for rapid disintegration in the mouth without the need for water, potentially offering improved convenience and faster onset compared to traditional oral tablets.
- Brand names
- SIL STRIPS
- Other names
- Sildenafil 50 mg ODFSildenafil50 mg ODFSildenafil-50 mg ODFsildenafil
02
Targets
PDE5 (Phosphodiesterase 5A)
Beyond the preview
Go deeper on SIL STRIPS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SIL STRIPS.